Circulating renin-angiotensin system and catecholamines in childhood: is there a role for birthweight?

Maria C P Franco1, Dulce E Casarini, Marcela S Carneiro-Ramos

  • 1Division of Nephrology, School of Medicine, Federal University of São Paulo, 04023-900 São Paulo, Brazil. mdcfranco@nefro.epm.br

Insights

Children born small for gestational age show overactivity in the sympathoadrenal and renin-angiotensin systems. This study links low birthweight to these systems

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Physiology
  • Developmental Biology

Background:

  • Limited research exists on sympathoadrenal and renin-angiotensin systems in small for gestational age (SGA) children.
  • Low birthweight is a potential risk factor for later cardiovascular issues.

Purpose of the Study:

  • To investigate plasma levels of angiotensin-converting enzyme (ACE) activity, angiotensin, and catecholamines in children aged 8–13 years.
  • To determine correlations between these systems and birthweight and blood pressure (BP).

Main Methods:

  • Clinical study of 66 children (35 boys, 31 girls) divided into appropriate-for-gestational age (AGA) and SGA groups.
  • Plasma concentrations of angiotensin, catecholamines, and ACE activity were measured.
  • Blood pressure levels were recorded.

Main Results:

  • Elevated noradrenaline in SGA girls compared to AGA girls (P=0.036).
  • Higher angiotensin II and ACE activity in SGA boys (P=0.024 and P=0.050, respectively).
  • Significant association between angiotensin II, ACE activity, and BP levels in the study population.

Conclusions:

  • Findings support a link between low birthweight and overactivity of sympathoadrenal and renin-angiotensin systems in childhood.
  • Mechanisms connecting restricted fetal growth to later cardiovascular events require further investigation.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...